New therapeutic approaches to type 1 diabetes: from prevention to cellular or gene therapies.
Thivolet
C
C
Endocrinology Department and INSERM 449, Faculté Laennec, Lyon, France. charles.thivolet@chu-lyon.fr
D000818:Animals; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D016923:Cell Death; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology / Q000517:prevention & control / Q000628:therapy*; D018014:Gene Transfer Techniques; D015316:Genetic Therapy / Q000379:methods; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D007328:Insulin / Q000235:genetics / Q000627:therapeutic use; D007515:Islets of Langerhans / Q000503:physiopathology; D016381:Islets of Langerhans Transplantation; D051379:Mice; D023421:Models, Animal; D010179:Pancreas / Q000276:immunology; D051381:Rats; D018417:Th1 Cells / Q000276:immunology
D000911:Antibodies, Monoclonal; D007328:Insulin